ÃâÒßѧÊÔÌâ
@yBg)1A
L Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
8hx4s(1! 1. Fas(CD95)/FasL
< ag|# 2. common chain of cytokine receptor
7Z-'@m 3 . TCR/CD3 complex
?\GILB, 4. negaive selection of thymocytes
9y BENvq 5. artificial active immune
RUJkfi=$ 6. anti-idiotypic
I~LN)hqd o 7. IgSF
a[<'%S#3x 8. Integrin
UL81x72O 9. chemokine
Dg^n`[WO 10. B7/CD28
%SKp<>;9 ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£©
8MHYk>O~{G 1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£
AXUSU(hU 2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£
o:H^
L,<Tl 3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ 4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£
Yp_ L.TTb 5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½
"O{_LOJ
d|GQZAEJEt 1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£
Gp0H[-oF µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ
+.Pv:7gh Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
pmm?Fq!s= 1. B7/CD28
hlY]s
&0 2. Th1 subset
hf6=`M}>i 3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£©
l)V!0eW 4. antibody affinity maturation
9`83cL 5. AP-1
VMry$ 6. single chain variable fragment£¨ScFv£©
tDW
W
4H 7. NK cell receptor
^/nj2" 8. Zinkernagel-Doherty phenomenon
W'aZw9 9. Ig fold
gN2$;hb? 10. CD40/CD40L
(IlHg^" ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£©
1&zvf4 1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£
Q5[x2 s_ d 2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿
M^q< qS>d 3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿
nz{
;]U1 Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩
IM.sW'E 1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£
_n6ge*,E 2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£
}tq 3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£
r]e1a\)r Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
t=,ZR}M1` £¨ÃâÒßѧרҵºÍרҵ»ù´¡£©
#'poDX? Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£©
1D*oXE9Ig 1.Co-stimulators (or co-stimulating molecules)
W''%{A/' 2.NK-kB
QO1pwrX< 3.Immunoglobulin superfamily
6Zr_W#SE 4.antigen-presenting cell (APC)
u|;?FQ$M 5.death domain
xwuGJ 6.CCR and CXCR
o,-p
[1b 7.Lectin (or mitogen)
s$%t*T2J> 8.Clusters of differentiation, CD)
u
Dtml$9rN 9.B7 family
X8}m
% 10.Cytotoxic T lymphocyte, CTL)
UL{+mp
11.IL-15 and IL-15 receptor (IL-15R)
=`MxgK + 12.MHC restriction
]=gNA 13.Affinity-chromatography
Vy.gr4Cm 14.Cyctosprin A, CsA
^sF/-/ {?U 15.Antibody-dependent cell-mediated cytotoxicity, ADCC)
7
KuUV!\h` ¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£©
Kw%to9eh) 1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿
CpE LLA< 2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£
Abw=x4d(i 3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£
OLH[F Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£©
}WowgY ÃâÒßѧרҵ£º
{PGiNY%q 1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£
!_?K(X~/ Ïû»¯ÄÚ¿Æ£º
XRl!~Y| 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£
{4F=].! ѪҺ²¡Ñ§×¨Òµ£º
e
2"<3 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿
C
vOH*K' Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
;b`kN;s (רҵ»ù´¡: ÃâÒßѧ)
nF5\iV Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö)
Y5ZBP?P 1. ADCC(antibody dependent cell-mediated cytotoxicity)
^ g'P
H{68 2. »·æß¾úËØ(cyclosporin)
B>;`$- 3. KIR(killer cell inhibitory receptor)
DqJzsk'
d3 4. HLDA(human leucocyte differentiation antigen)
<eh<4_<qF 5. Interleukin 18(IL-18)
;RW0Dn)Q 6. ÕûºÏËØ(integrin)
T5_/*`F 7. Fas/FasL
a5k![sw\ 8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå)
1CR)1H 9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM)
O>@
ChQF 10. Th1/Th2
vWH)W?2 11. »ùÒòÒßÃç(DNAÒßÃç)
9dO. ,U*` 12. chemokines and chemokine receptor
PL|ea~/ 13. ÃâÒßÄÍÊÜ
o.g)[$M8cF 14. ¹²´Ì¼¤·Ö×Ó
K'c[r0Ew 15. ËÀÍö½á¹¹Óò(death domain)
I_s* pT ¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö)
YXLZ2-%ohZ 1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬?
0K(&EpVE 2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óá£
PQrc#dfc| £¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î
1oI2 £¨2£©1977Ä꣺·ÅÉäÃâÒß·¨
98*C/=^TH{ £¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå
^g=j`f[T £¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹
!>:]k?$b 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£
fwi
- Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ)
d^Rea
8 ÎÊ´ðÌâ(ÿÌâ25·Ö)
nP0rg 1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£
fLZ99?J 2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿
;NF:98 3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£
4t 0p!IxG 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£